Agenus brain cancer vaccine improves survival in mid-stage study
(Reuters) - Biotechnology company Agenus Inc said its experimental brain cancer vaccine increased the survival of patients without their cancer worsen...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/RAp9z37H9XY/story01.htm
No comments:
Post a Comment